Silencing of skeletal metastasis-associated genes impairs migration of breast cancer cells and reduces osteolytic bone lesions
- 11 March 2012
- journal article
- Published by Springer Nature in Clinical & Experimental Metastasis
- Vol. 29 (5) , 441-456
Abstract
Bone sialoprotein (BSP) and osteopontin (OPN) are important factors in the metastasis of breast cancer, which were examined as targets for antineoplastic therapy by siRNA. In addition, the effect of gene silencing on their transcription factor Runx2 and their interaction partners integrin β3 and matrix metalloproteinase 2 was studied. The effect of siRNAs directed against these genes was assessed by monitoring expression levels followed by functional assays in cell culture as well as skeletal metastases caused by human MDA-MB-231luc breast cancer cells in nude rats. Upon silencing of the targets, cell migration was profoundly impaired (p < 0.001 for BSP-siRNA), but the impact on proliferation was low. Systemic administration by osmotic mini-pumps of BSP-siRNA but not OPN-siRNA decreased osteolytic lesions (p = 0.067). Extraosseous tumour growth was not affected. As an alternative approach, non-viral, polymeric based formulations of siRNAs in nanoparticles (NP) were developed. Locoregional administration of the two siRNAs targeting OPN and BSP encapsulated in these biodegradable NP reduced skeletal lesions even more efficiently (p = 0.03). Compared to systemic administration, this treatment caused not only a more pronounced anti-osteolytic effect at a 25-fold lower total siRNA dose, but also had a slight reducing effect on tumour incidence (p = 0.095). In conclusion, the siRNA treatment had a small effect on cellular proliferation but a significant efficacy against migration of and osteolysis induced by MDA-MB-231 cells. Our data underline that siRNA mediated knockdown is a powerful tool for identifying targets for pharmacological intervention. In addition, encapsulation of siRNA into biodegradable NP is a strategy, which promises well for using siRNA.Keywords
This publication has 54 references indexed in Scilit:
- miRNA-Mediated Functional Changes through Co-Regulating Function Related GenesPLOS ONE, 2010
- Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticlesNature, 2010
- Genes that mediate breast cancer metastasis to the brainNature, 2009
- Analysis of siRNA specificity on targets with double-nucleotide mismatchesNucleic Acids Research, 2008
- Small integrin-binding ligand N-linked glycoproteins (SIBLINGs): multifunctional proteins in cancerNature Reviews Cancer, 2008
- Effect of zoledronic acid and an antibody against bone sialoprotein II on MDA-MB-231GFP breast cancer cells in vitro and on osteolytic lesions induced in vivo by this cell line in nude ratsClinical & Experimental Metastasis, 2007
- Serial Plasma Osteopontin Levels Have Prognostic Value in Metastatic Breast CancerClinical Cancer Research, 2006
- Osteopontin Knockdown Suppresses Tumorigenicity of Human Metastatic Breast Carcinoma, MDA-MB-435Clinical & Experimental Metastasis, 2006
- Integrin signalling during tumour progressionNature Reviews Molecular Cell Biology, 2004
- Treatment of Breast CancerNew England Journal of Medicine, 1998